I apologize for the suspected phrase. Here is the revised response without the unnecessary description:
India is facing an impending diabetes epidemic, with a large number of people currently living with diabetes and many more at high risk of developing the condition in the next few years. In response to this alarming situation, Fitterfly, a healthtech company, has introduced JEDi, an AI-enabled conversational coaching tool aimed at transforming diabetes interventions in India.
The existing care for diabetes in the country has certain gaps that digital therapeutic solutions are trying to bridge. However, the magnitude of the problem requires an additional solution that can operate effectively at scale while providing personalized, intelligent, and accessible care for the masses.
JEDi, developed by Fitterfly’s X-labs Innovation team, is an empathetic AI coach that offers guidance in managing nutrition, fitness, and overall well-being through a 28-day interactive regimen. It analyzes user responses, health data, and preferences to provide customized advice and encouragement for adopting healthier habits.
The architecture of JEDi is a combination of rule-based Natural Language Processing (NLP) on an Expert system foundation and large language models (LLMs). It is connected to Fitterfly’s knowledge base, which powers their therapies. The developers have given JEDi a personality that prioritizes patient care and outcomes above all.
JEDi is now available through the Fitterfly Metabolic Health app and can also be used by corporates to support employee wellness. It is expected to play a role in patient support programs and be offered as an add-on service by insurance companies.
Fitterfly’s COO and co-founder, Shailesh Gupta, believes that utilizing AI in digital therapeutics can lead to improved patient outcomes. JEDi is the first product from Fitterfly’s Innovation Lab and demonstrates their belief in the power of AI to provide scalable solutions.
The goal of JEDi is to seamlessly integrate with existing healthcare systems, providing data-driven insights that empower patients in self-management and contribute to more cost-efficient healthcare. The introduction of JEDi aims to alleviate the burden of diabetes on India’s healthcare system.
For more information on implementing JEDi for corporate or healthcare solutions, interested parties can email [email protected]
Fitterfly is a leading healthtech company specializing in metabolic health and offers digital therapeutic programs for conditions such as diabetes, obesity, and heart disease. It was founded in 2016 by Dr. Arbinder Singal and Shailesh Gupta in Mumbai. The company has received several awards and recognition for its innovative research and has raised significant funding from investors like Amazon, Fireside Ventures, and Venture Catalysts.
